Safety and Immunogenicity of a Subunit Trivalent Influenza Vaccine, Northern Hemisphere Formulation 2013/2014, Including MF59C.1 Adjuvant, in Healthy Adults ≥65 Years of Age
Clinical trial NCT01879540 · COMPLETED
Trial details
- NCT number
- NCT01879540
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2013-08-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.